Silverback Therapeutics shares owned by Balyasny Asset Management
Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Balyasny Asset Management
from 13F filings
Historical chart of Balyasny Asset Management investment in Silverback Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Silverback Therapeutics held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Silverback Therapeutics by Balyasny Asset Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $96k | 17k | 5.48 |
2022-12-31 | $97k | 11k | 8.53 |